CALGARY, Oct. 24, 2019 /CNW/ - Nanalysis Scientific
Corp. (the "Company" or "Nanalysis",
TSX-V: NSCI), is pleased to announce that Luke Caplette is joining the company as its
Chief Financial Officer (CFO). Mr. Caplette, CPA/CA, spent the
early part of his career at Ernst & Young as Senior Accountant
and was most recently CFO at Cordy Oilfield Services Inc.
Luke Caplette states: "I am
excited to be joining the Nanalysis team. I've listened to the
Company's plan to scale its business globally, and I'm looking
forward to being a part of that vision. Nanalysis has commercially
successful technology products, a very interesting growth roadmap,
and I look forward to bringing my financial and process acumen to
complement the current Nanalysis team."
Sean Krakiwsky, CEO of Nanalysis
added: "Rapid growth always presents challenges related to internal
process and Luke has great experience, as demonstrated through his
service at Cordy Oilfield Services, putting in place the kind of
financial controls that will allow us to continue to execute our
strategy while ensuring our financial foundation is perfectly
aligned."
Mr. Caplette's appointment as Nanalysis CFO is effective
October 28th. Current CFO,
Mr. Gary Reavie, will remain with
the company in a part-time capacity. Nanalysis thanks Mr. Reavie
for his excellent service as CFO over the past 2 years, which was
instrumental in the company's success and in the process of taking
the Company public.
The Company also announces that it is granting stock options to
acquire up to 525,000 common shares of the Company to certain of
its employees, consultants, officers and directors. The options
have an exercise price of $0.60 per
common share and expire on October 28,
2024.
About Nanalysis Scientific Corp. (TSX-V: NSCI,
FRA:1N1)
Nanalysis trades on the TSX Venture Exchange in Canada with ticker symbol 'NSCI'. The
Company's business is what we term "MRI for industry": it develops
and manufactures portable Nuclear Magnetic Resonance (NMR)
spectrometers or analyzers for laboratory and industrial markets.
The NMReady-60™ was the first fully featured portable NMR
spectrometer in a single compact enclosure requiring no liquid
helium or any other cryogens, and the company has followed-up that
initial offering with new products and continues to have a strong
innovation pipeline. The Company recently announced that it will
begin selling a 100MHz device in early 2020. The Company's new
device will be the most powerful non-cryogen, permanent magnet NMR
device ever brought to market.
Nanalysis devices are used by chemical professionals in many
industries (oil and gas, chemical, mining, pharma, biotech, flavor
and fragrances, agrochemicals, and more) as well as numerous
government and university research labs around the world. The
company continues to exploit new global market opportunities
independently and with partners.
Notice regarding Forward Looking Statements and Legal
Disclaimer
This news release contains certain "forward-looking statements"
within the meaning of such statements under applicable securities
law. Forward-looking statements are frequently characterized by
words such as "anticipates", "plan", "continue", "expect",
"project", "intend", "believe", "anticipate", "estimate", "may",
"will", "potential", "proposed", "positioned" and other similar
words, or statements that certain events or conditions "may" or
"will" occur. These statements are only predictions. Various
assumptions were used in drawing the conclusions or making the
projections contained in the forward-looking statements throughout
this news release. Forward-looking statements are based on the
opinions and estimates of management at the date the statements are
made and are subject to a variety of risks and uncertainties and
other factors that could cause actual events or results to differ
materially from those projected in the forward-looking statements.
The Corporation is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable law.
The TSX Venture Exchange or other regulatory authority has not
reviewed, approved or disapproved the contents of this press
release. We seek safe harbor.
SOURCE Nanalysis Scientific Corp.